Search - tctmd.com

Displaying 21 - 40 of 260

Sort: Relevancy | Date

Presentation TCT 2022

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Presenter: Brian Whisenant

September 18, 2022

Presentation TCT 2022

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Presenter: Linda Gillam

September 18, 2022

Presentation TCT 2022

Insights from the CLASP IID Registry

Presenter: Jörg Hausleiter

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

Results and benefits of aortic intervention in the US by age.

Presenter: Megan Coylewright

September 18, 2022

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

Presentation TCT 2022

The Impact of Unloading: What We May Learn from the STEMI DTU RCT

Presenter: Navin Kapur

September 18, 2022

Presentation TCT 2022

Contemporary Techniques for Optimal Outcomes in High-Risk PCI

Presenter: Kate Kearney

September 18, 2022

Presentation TCT 2022

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Presenter: Adam Salisbury

September 18, 2022

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Presenter: Sandeep Basavarajaiah

September 18, 2022

Presentation TCT 2022

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Presenter: Bernardo Cortese

September 18, 2022

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Presenter: Aloke Finn

September 18, 2022

Presentation TCT 2022

Introduction & Session Objectives

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

TARGET First: Short DAPT with Complete Revascularization Strategy

Presenter: Giuseppe Tarantini

September 18, 2022

Presentation TCT 2022

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Presenter: Alexandra Lansky

September 18, 2022

Presentation TCT 2022

Expanding Treatment Population

Presenter: Rahul Sharma

September 17, 2022

Advertisement

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Insights from the CLASP IID Registry

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Results and benefits of aortic intervention in the US by age.

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

The Impact of Unloading: What We May Learn from the STEMI DTU RCT

Contemporary Techniques for Optimal Outcomes in High-Risk PCI

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

DCB in CAD: understanding the existing and new indications

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Introduction & Session Objectives

Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

TARGET First: Short DAPT with Complete Revascularization Strategy

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Expanding Treatment Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content